Source:http://linkedlifedata.com/resource/pubmed/id/17054217
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-10-20
|
pubmed:abstractText |
Crohn's disease (CD) is characterised by episodes of disease activity and symptom-free remission. Probiotics are microorganisms that can potentially benefit health, and have been evaluated as an alternate means of preventing relapse in patients with CD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD004826
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17054217-Adult,
pubmed-meshheading:17054217-Child,
pubmed-meshheading:17054217-Crohn Disease,
pubmed-meshheading:17054217-Humans,
pubmed-meshheading:17054217-Probiotics,
pubmed-meshheading:17054217-Randomized Controlled Trials as Topic,
pubmed-meshheading:17054217-Remission Induction
|
pubmed:year |
2006
|
pubmed:articleTitle |
Probiotics for maintenance of remission in Crohn's disease.
|
pubmed:affiliation |
The University of De Montford, School of Allied Health Sciences, Hawthorn Building, Leicester, UK. vrolfe@dmu.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|